Muscular Dystrophy Animations

Researchers discover fundamental pathology behind ALS
A team led by scientists at St. Jude Children's Research Hospital and Mayo Clinic has identified a basic biological mechanism that kills neurons in amyotrophic lateral sclerosis (ALS) and in a...

Scientists prevent neurodegeneration-associated protein clumping in lab study
Scientists report in a new study that by imitating a natural process of cells, they prevented the formation of protein clumps associated with amyotrophic lateral sclerosis (ALS) and frontotemporal...

Clinical trial shows some promise for Duchenne muscular dystrophy drug
The results of an international clinical trial, led in part by a UC Davis School of Medicine expert, have shown that a drug therapy for a severe type of muscular dystrophy holds promise for a...

New discovery in MND and dementia could pave the way to novel treatments
New discovery in motor neurone disease and dementia could pave the way to novel treatments.

New gene therapy treatment routes for motor neurone disease uncovered in new study
Scientists investigating the genetic causes and altered functioning of nerve cells in motor neurone disease (MND) have discovered a new mechanism that could lead to fresh treatment approaches for one...

What percentage of ALS is genetic?
Up to 90 percent of people with amyotrophic lateral sclerosis (ALS) report that they have no family history of the disease.

Study shows drug lowers levels of biomarker linked to ALS
A new study finds that a decades-old drug used to treat malaria lowers levels of a biomarker linked to the inherited form of amyotrophic lateral sclerosis, also known as ALS and Lou Gehrig's Disease.

One gene closer to regenerative therapy for muscular disorders
A detour on the road to regenerative medicine for people with muscular disorders is figuring out how to coax muscle stem cells to fuse together and form functioning skeletal muscle tissues.

Motor neuron disease discovery offers new insights into potential treatment targets
Scientists have discovered how certain forms of motor neuron disease begin and progress at cellular and molecular levels, revealing potential new ways to slow down or even stop this process.

MS vs. ALS: Differences, causes, and treatment
MS and ALS both affect the central nervous system, but in different ways. Learn about the key differences between the two, specific symptoms, and outlook.

Weekly steroids strengthen and repair muscles
Weekly doses of glucocorticoid steroids, such as prednisone, help speed recovery in muscle injuries, reports a new Northwestern Medicine study.

FDA approves drug to treat ALS
The U.S. Food and Drug Administration approves Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig's disease.

Gene silencing shows promise for treating two fatal neurological disorders
In two studies of mice, researchers showed that a drug, engineered to combat the gene that causes spinocerebellar ataxia type 2 (SCA2), might also be used to treat amyotrophic lateral sclerosis...

A new marker for the most common form of ALS
A molecule found in blood and cerebrospinal fluid could serve as an indicator for the most common form of amyotrophic lateral sclerosis (ALS), offering a much needed tool to measure disease...

Occupational exposure to magnetic fields increases risk of ALS
A new study finds that high exposure to extremely low-frequency magnetic fields through work significantly increases the risk of dying from ALS.